Alembic Pharmaceuticals Ltd received final approval from the USFDA for its generic Difluprednate ophthalmic emulsion, used to treat eye inflammation and pain post-surgery. This approval marks a ...
Alembic Pharmaceuticals was sued for patent infringement on Dec. 19 in New York Eastern District Court for seeking to market a generic version of glaucoma treatment Lumigan. The action, brought by ...
International consultancy Accenture announced last week that it had invested in AI startup Alembic, kickstarting a partnership that will leverage the technology to better measure the effectiveness of ...
Led by Prysm Capital and Accenture with participation from Silver Lake Waterman, Liquid 2 Ventures, NextEquity, Friends & Family Capital, and WndrCo, this round positions Alembic among the top AI labs ...
Accenture (NYSE: ACN) has invested, through Accenture Ventures, in Alembic, a leading AI-powered causal marketing intelligence platform that can determine which marketing campaigns deliver a return on ...
Causal artificial intelligence startup Alembic Technologies Inc. said today it has raised $145 million in a Series B growth round that increases its valuation almost 16-fold. It’s using a big chunk of ...
Alembic, a startup that offers AI-powered data analytics for marketers, said it has raised $145 million in a fundraising round that values the company at $645 million. Alembic’s software is designed ...
Alembic Technologies has raised $145 million in Series B and growth funding at a valuation 15 times higher than its previous round, betting that the next competitive advantage in artificial ...
Introduce a persistent database layer so activities and participants survive server restarts. Use SQLAlchemy as the ORM and Alembic for migrations. Keep the current ...
The topical cream is indicated for the treatment of acne. Clobetasol propionate foam is indicated for the treatment of moderate to severe plaque psoriasis of the scalp and mild to moderate plaque ...
A trio of Indian drugmakers—Alembic Pharmaceuticals, Sun Pharmaceutical and Glenmark Pharmaceuticals—issued separate voluntary U.S. drug recalls in recent weeks due to either the presence of ...
Alembic Pharmaceuticals Ltd.'s proposed copies of the prostate-cancer treatment Nubeqa infringe four patents Orion Corp. licenses to Bayer AG, a federal lawsuit said. The patents cover darolutamide ...